Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

R. T. Eagan, S. Frytak, E. T. Creagan, J. N. Ingle, L. K. Kvols, D. T. Coles

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The evaluation of cyclophosphamide, Adriamycin, and cis-platinum given by 6-hour infusion with mannitol (CAP-II) is the subject of this report. Forty-two patients, 22 with adenocarcinoma (ACA) and 20 with large cell carcinoma (LCC) of the lung, were entered in the study.

Original languageEnglish (US)
Pages (from-to)1589-1591
Number of pages3
JournalCancer Treatment Reports
Volume63
Issue number9-10
StatePublished - 1979
Externally publishedYes

Fingerprint

Large Cell Carcinoma
Mannitol
Doxorubicin
Cyclophosphamide
Cisplatin
Adenocarcinoma
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung. / Eagan, R. T.; Frytak, S.; Creagan, E. T.; Ingle, J. N.; Kvols, L. K.; Coles, D. T.

In: Cancer Treatment Reports, Vol. 63, No. 9-10, 1979, p. 1589-1591.

Research output: Contribution to journalArticle

Eagan, R. T. ; Frytak, S. ; Creagan, E. T. ; Ingle, J. N. ; Kvols, L. K. ; Coles, D. T. / Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung. In: Cancer Treatment Reports. 1979 ; Vol. 63, No. 9-10. pp. 1589-1591.
@article{b9bf8dcefe264ad58c57b37f8c2315c0,
title = "Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung",
abstract = "The evaluation of cyclophosphamide, Adriamycin, and cis-platinum given by 6-hour infusion with mannitol (CAP-II) is the subject of this report. Forty-two patients, 22 with adenocarcinoma (ACA) and 20 with large cell carcinoma (LCC) of the lung, were entered in the study.",
author = "Eagan, {R. T.} and S. Frytak and Creagan, {E. T.} and Ingle, {J. N.} and Kvols, {L. K.} and Coles, {D. T.}",
year = "1979",
language = "English (US)",
volume = "63",
pages = "1589--1591",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "9-10",

}

TY - JOUR

T1 - Phase II study of cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) by infusion in patients with adenocarcinoma and large cell carcinoma of the lung

AU - Eagan, R. T.

AU - Frytak, S.

AU - Creagan, E. T.

AU - Ingle, J. N.

AU - Kvols, L. K.

AU - Coles, D. T.

PY - 1979

Y1 - 1979

N2 - The evaluation of cyclophosphamide, Adriamycin, and cis-platinum given by 6-hour infusion with mannitol (CAP-II) is the subject of this report. Forty-two patients, 22 with adenocarcinoma (ACA) and 20 with large cell carcinoma (LCC) of the lung, were entered in the study.

AB - The evaluation of cyclophosphamide, Adriamycin, and cis-platinum given by 6-hour infusion with mannitol (CAP-II) is the subject of this report. Forty-two patients, 22 with adenocarcinoma (ACA) and 20 with large cell carcinoma (LCC) of the lung, were entered in the study.

UR - http://www.scopus.com/inward/record.url?scp=0018610429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018610429&partnerID=8YFLogxK

M3 - Article

C2 - 227597

AN - SCOPUS:0018610429

VL - 63

SP - 1589

EP - 1591

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 9-10

ER -